Literature DB >> 12652054

Influence of apolipoprotein e polymorphism on cardiovascular risk factors in obese children.

António Guerra1, Carla Rego, Elizabete M B Castro, Susana Seixas, Jorge Rocha.   

Abstract

AIM: The main objective of the study was to determine whether risk factors associated with obesity are influenced by genetic variation of apolipoprotein E (ApoE).
METHODS: 81 obese children (mean age 9.4 +/- 2.8 years) and an age-matched control group were included. Body composition, lipid profile, and glucose and insulin levels were evaluated according to international recommendations, and the blood pressure was measured by an oscillometric method.
RESULTS: The calculated frequencies of the ApoE alleles *2, *3, and *4 (0.04, 0.88 and 0.08) in obese children were similar to those of eutrophic age-matched controls (0.07, 0.82, and 0.11) and fitted the range of variation generally observed in southern European populations. Age, anthropometric parameters, body fat mass, and blood pressure were similar in E2/3, E3/3 and E4/3 genotypes. Total/high-density lipoprotein cholesterol and low-density lipoprotein/high-density lipoprotein cholesterol ratios were higher in the E4/3 group as compared with E3/3 (p < 0.01) and E2/3 (p < 0.05) groups. No differences concerning clusters of risk factors were observed among the three genotypes. No associations were found between ApoE polymorphism and glucose levels (fasting and at 2 h) and between fasting insulin levels and HOMA(IR) results. Higher levels of fasting and 2-hour insulin and higher HOMA(IR) values were significantly associated with a higher fat mass.
CONCLUSIONS: ApoE polymorphism seems to influence some lipid profile abnormalities associated with obesity in childhood. However, clustering of risk factors and insulin resistance seem not to be dependent on ApoE polymorphism. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12652054     DOI: 10.1159/000069275

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  8 in total

1.  The apolipoprotein E gene and Taq1A polymorphisms in childhood obesity.

Authors:  Mehmet Ali Ergun; Meral Yirmibes Karaoguz; Altug Koc; Orhun Camurdan; Aysun Bideci; A Canan Yazici; Peyami Cinaz
Journal:  Genet Test Mol Biomarkers       Date:  2010-06

2.  Association of cholesteryl ester transfer protein (TaqIB) and apolipoprotein E (HhaI) gene variants with obesity.

Authors:  Neena Srivastava; B R Achyut; Jai Prakash; C G Agarwal; D C Pant; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-05-04       Impact factor: 3.396

3.  Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention.

Authors:  José M Ordovas
Journal:  Am J Clin Nutr       Date:  2009-04-01       Impact factor: 7.045

4.  The apolipoprotein E polymorphism rs7412 associates with body fatness independently of plasma lipids in middle aged men.

Authors:  M Teresa Tejedor; Maria Pilar Garcia-Sobreviela; Marta Ledesma; Jose M Arbones-Mainar
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  Association of apolipoprotein E polymorphism with plasma lipid disorders, independent of obesity-related traits in Vietnamese children.

Authors:  Nguyen Thi Hong Hanh; Bui Thi Nhung; Duong Thi Anh Dao; Le Thi Tuyet; Le Thi Hop; Tran Quang Binh; Vu Thi Minh Thuc
Journal:  Lipids Health Dis       Date:  2016-10-10       Impact factor: 3.876

6.  Apolipoprotein E Genotype and Sex Influence Glucose Tolerance in Older Adults: A Cross-Sectional Study.

Authors:  Angela J Hanson; William A Banks; Hector Hernandez Saucedo; Suzanne Craft
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-03-16

Review 7.  Development of hypertension in overweight adolescents: a review.

Authors:  Rebecca K Kelly; Costan G Magnussen; Matthew A Sabin; Michael Cheung; Markus Juonala
Journal:  Adolesc Health Med Ther       Date:  2015-10-21

8.  Influence of Apolipoprotein E on the Lipid Profile and Postprandial Triglyceride Levels in Brazilian Postmenopausal Women With Artery Disease.

Authors:  Lúcia Helena Bonalume Tácito; Lilian Nakachima Yamada; Marcela Augusta de Souza Pinhel; Juan Carlos Yugar-Toledo; Dorotéia Rossi Silva Souza
Journal:  Clin Med Insights Cardiol       Date:  2017-09-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.